Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117415) titled 'Evaluation of the Efficacy and Safety of Acellular Allogeneic Dermal Matrix in Posterior Scleral Reinforcement Surgery' on Jan. 23.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Eye Hospital, Wenzhou Medical University
Condition:
Progressive pathological myopia
Intervention:
ADM-PSR Group:Posterior Scleral Reinforcement (PSR)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-26
Target Sample Size: ADM-PSR Group:39;Homologous Dura Mater PSR Group:39;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...